-
1
-
-
33751284806
-
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
-
Zakikhani M, Dowling R, Fantus IG et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 2006;66: 10269-10273.
-
(2006)
Cancer Res
, vol.66
, pp. 10269-10273
-
-
Zakikhani, M.1
Dowling, R.2
Fantus, I.G.3
-
2
-
-
84884211823
-
Targeting metabolism for cancer treatment and prevention: Metformin, an old drug with multifaceted effects
-
Pierotti MA, Berrino F, Gariboldi M et al. Targeting metabolism for cancer treatment and prevention: Metformin, an old drug with multifaceted effects. Oncogene 2013;32:1475-1487.
-
(2013)
Oncogene
, vol.32
, pp. 1475-1487
-
-
Pierotti, M.A.1
Berrino, F.2
Gariboldi, M.3
-
3
-
-
84890016628
-
Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: A systematic review and meta-analysis
-
Yin M, Zhou J, Gorak EJ et al. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: A systematic review and meta-analysis. The Oncologist 2013;18: 1248-1255.
-
(2013)
The Oncologist
, vol.18
, pp. 1248-1255
-
-
Yin, M.1
Zhou, J.2
Gorak, E.J.3
-
4
-
-
84886557970
-
Metformin use and all-cause and prostate cancerspecific mortality among men with diabetes
-
Margel D, Urbach DR, Lipscombe LL et al. Metformin use and all-cause and prostate cancerspecific mortality among men with diabetes. J Clin Oncol 2013;31:3069-3075.
-
(2013)
J Clin Oncol
, vol.31
, pp. 3069-3075
-
-
Margel, D.1
Urbach, D.R.2
Lipscombe, L.L.3
-
5
-
-
84881624670
-
Association between metformin use and risk of prostate cancer and its grade
-
Margel D, Urbach D, Lipscombe LL et al. Association between metformin use and risk of prostate cancer and its grade. J Natl Cancer Inst 2013;105:1123-1131.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1123-1131
-
-
Margel, D.1
Urbach, D.2
Lipscombe, L.L.3
-
6
-
-
84902550277
-
Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma
-
Sandulache VC, Hamblin JS, Skinner HD et al. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head Neck 2014;36:1039-1043.
-
(2014)
Head Neck
, vol.36
, pp. 1039-1043
-
-
Sandulache, V.C.1
Hamblin, J.S.2
Skinner, H.D.3
-
7
-
-
84881524522
-
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer
-
Klubo-Gwiezdzinska J, Costello J Jr., Patel A et al. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab 2013;98:3269-3279.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 3269-3279
-
-
Klubo-Gwiezdzinska, J.1
Costello, J.2
Patel, A.3
-
8
-
-
84885167225
-
Metformin and survival in pancreatic cancer: A retrospective cohort study
-
Hwang AL, Haynes K, Hwang WT et al. Metformin and survival in pancreatic cancer: A retrospective cohort study. Pancreas 2013;42:1054-1059.
-
(2013)
Pancreas
, vol.42
, pp. 1054-1059
-
-
Hwang, A.L.1
Haynes, K.2
Hwang, W.T.3
-
9
-
-
84890429862
-
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma
-
Kim JW, Roh JL, Kim JS et al. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma. Br J Cancer 2013;109:2973-2979.
-
(2013)
Br J Cancer
, vol.109
, pp. 2973-2979
-
-
Kim, J.W.1
Roh, J.L.2
Kim, J.S.3
-
11
-
-
34447266437
-
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
-
Hashibe M, Brennan P, Benhamou S et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99:777-789.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 777-789
-
-
Hashibe, M.1
Brennan, P.2
Benhamou, S.3
-
12
-
-
1542532754
-
A proportional hazards model for the subdistribution of acompeting risk
-
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of acompeting risk. J AmStat Assoc 1999;94:496-509.
-
(1999)
J Amstat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
13
-
-
58049192725
-
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus:Asystematic reviewandmetaanalysis
-
Barone BB, Yeh HC, Snyder CF et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus:Asystematic reviewandmetaanalysis. JAMA 2008;300:2754-2764.
-
(2008)
JAMA
, vol.300
, pp. 2754-2764
-
-
Barone, B.B.1
Yeh, H.C.2
Snyder, C.F.3
-
15
-
-
79551510805
-
Obesity and cancer risk: Recent review and evidence
-
Basen-Engquist K, Chang M. Obesity and cancer risk: Recent review and evidence. Curr Oncol Rep 2011;13:71-76.
-
(2011)
Curr Oncol Rep
, vol.13
, pp. 71-76
-
-
Basen-Engquist, K.1
Chang, M.2
-
16
-
-
38949108241
-
Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies
-
Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
-
(2008)
Lancet
, vol.371
, pp. 569-578
-
-
Renehan, A.G.1
Tyson, M.2
Egger, M.3
-
17
-
-
77953537179
-
Glucoselowering agents and cancer mortality rates in type 2 diabetes: Assessing effects of time-varying exposure
-
Bowker SL, Yasui Y, Veugelers P et al. Glucoselowering agents and cancer mortality rates in type 2 diabetes: Assessing effects of time-varying exposure. Diabetologia 2010;53:1631-1637.
-
(2010)
Diabetologia
, vol.53
, pp. 1631-1637
-
-
Bowker, S.L.1
Yasui, Y.2
Veugelers, P.3
-
18
-
-
0036511152
-
Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines
-
Begum NM, Nakashiro K, Kawamata H et al. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines. Int J Oncol 2002;20:599-605.
-
(2002)
Int J Oncol
, vol.20
, pp. 599-605
-
-
Begum, N.M.1
Nakashiro, K.2
Kawamata, H.3
-
19
-
-
1642293386
-
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptorgamma
-
Nakashiro K, Begum NM, Uchida D et al. Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptorgamma. Oral Oncol 2003;39:855-861.
-
(2003)
Oral Oncol
, vol.39
, pp. 855-861
-
-
Nakashiro, K.1
Begum, N.M.2
Uchida, D.3
-
20
-
-
84891824463
-
Pioglitazone and oral cancer risk in patients with type 2 diabetes
-
Tseng CH. Pioglitazone and oral cancer risk in patients with type 2 diabetes. Oral Oncol 2014;50: 98-103.
-
(2014)
Oral Oncol
, vol.50
, pp. 98-103
-
-
Tseng, C.H.1
-
21
-
-
84899135577
-
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptorpositive postmenopausal breast cancer (METEOR)
-
Kim J, Lim W, Kim EK et al. Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptorpositive postmenopausal breast cancer (METEOR). BMC Cancer 2014;14:170.
-
(2014)
BMC Cancer
, vol.14
, pp. 170
-
-
Kim, J.1
Lim, W.2
Kim, E.K.3
-
22
-
-
84882914592
-
Impact of targeting insulin-like growth factor signaling in head and neck cancers
-
Limesand KH, Chibly AM, Fribley A. Impact of targeting insulin-like growth factor signaling in head and neck cancers. Growth Horm IGF Res 2013;23: 135-140.
-
(2013)
Growth Horm IGF Res
, vol.23
, pp. 135-140
-
-
Limesand, K.H.1
Chibly, A.M.2
Fribley, A.3
-
23
-
-
84903897547
-
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer
-
Kwon M, Roh JL, Song J et al. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. Ann Oncol 2014;25:1208-1214.
-
(2014)
Ann Oncol
, vol.25
, pp. 1208-1214
-
-
Kwon, M.1
Roh, J.L.2
Song, J.3
-
24
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
|